NCT02655913

Phase I-II Study of Vitamin C Infusion in Combination With Local mEHT on Non Small Cell Lung Cancer Patients

Extracted Fields (from Registry)
Protocol IDNCT02655913
Registration Date2016-01-14
Statuscompleted
SponsorClifford Hospital, Guangzhou, China
CountryChina
Industrynot industry
Blindingblinded
Center Typesingel-center RCT
Scopenational RCT
First Patient In2015-12-01
Last Patient Out2018-08-01
Publicationn
Gender %ALL
Mean Age18 Years - 70 Years
LLM Classifications (Side-by-Side)
Field CLAUDE
claude-sonnet-4-20250514
5482ms / 10826 tok
GLM
glm-5.1
7684ms / 9462 tok
OPENAI
gpt-4o
Thinking: o3
3231ms / 9308 tok
Review
rct_type parallel RCT parallel RCT parallel RCT OK
cancer_status Cancer Cancer Cancer OK
non_cancer_spec N/A N/A N/A OK
setting_patient outpatient outpatient outpatient OK
setting_place hospital hospital hospital OK
feasibility fully powered RCT fully powered RCT fully powered RCT OK
intervention_pharmacologic yes yes yes OK
intervention_chemo_immuno_radio no no no OK
intervention_complementary yes yes yes → yes
shaky reasoning
✗ No consensus Initial: yes Requery: yes — Vitamin C (ascorbate) infusion is utilized in this trial as an alternative and complementary anticancer therapy.
no no → no → yes
shaky reasoning
✗ No consensus Initial: no Requery: no — The trial involves vitamin C infusion and modulated electro-hyperthermia, which are not classified as CAM modalities such as acupuncture, aromatherapy, massage, reflexology, yoga, meditation, Reiki, or herbal remedies. Thinking: yes — High-dose intravenous vitamin C is an alternative/dietary supplement therapy, qualifying as a complementary modality.
intervention_device yes yes yes OK
intervention_psychological no no no OK
intervention_complex yes yes yes OK
intervention_acp no no no OK
intervention_music no no no OK
intervention_screening no no no OK
intervention_palliative yes no no
intervention_education no no no OK
intervention_digital no no no OK
intervention_other no no no OK
outcome_symptom no no no OK
outcome_qol yes yes yes OK
outcome_dignity no no no OK
outcome_cost no no no OK
outcome_other yes yes yes OK
pharmacologic_sub other other other OK
Back to Studies